Clinical Trial Update: W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial in healthy volunteers evaluated the photoallergic potential of a combination topical gel containing clindamycin phosphate 1.0% and tretinoin 0.025…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Clindamycin Phosphate 1.0% (clindamycin phosphate)
• Tretinoin 0.025% (tretinoin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED